Lee, J. ., Kim, I. ., Cho, J. ., Lee, T. ., Park, J. ., Ahn, J. ., … Kang, I. . (2018). Vanillin improves scopolamine‑induced memory impairment through restoration of ID1 expression in the mouse hippocampus. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.8401 (Original work published 2018)

Ahn, J. ., Park, J. ., Park, J. ., Shin, M. ., Cho, J. ., Kim, I. ., … Choi, S. . (2018). Long-term treadmill exercise improves memory impairment through restoration of decreased synaptic adhesion molecule 1/2/3 induced by transient cerebral ischemia in the aged gerbil hippocampus. Experimental Gerontology. https://doi.org/10.1016/j.exger.2018.01.015 (Original work published 2018)

Bae, J. ., Ahn, J. ., Tantry, U. ., Gurbel, P. ., & Jeong, Y. . (2018). Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? Focused on ACS or PCI-treated Patients. Current Vascular Pharmacology. https://doi.org/10.2174/1570161116666180117103238 (Original work published 2018)

Yoon, J. ., Lee, J. ., Gu, S. ., Jung, M. ., Cho, H. ., Lim, J. ., … Kim, N. . (2017). Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma. Oncotarget, 8(68), 112610-112622. https://doi.org/10.18632/oncotarget.22614 (Original work published 2017)

Park, J. ., Cho, J. ., Ahn, J. ., Choi, S. ., Lee, T. ., Lee, J. ., … Kang, I. . (2018). Neuronal loss and gliosis in the rat striatum subjected to 15 and 30 minutes of middle cerebral artery occlusion. Metabolic Brain Disease. https://doi.org/10.1007/s11011-018-0192-8 (Original work published 2018)

Park, J. ., Lee, T. ., Ahn, J. ., Shin, B. ., Cho, J. ., Kim, I. ., … Won, M. . (2017). Pre-treated <i>Populus tomentiglandulosa</i> extract inhibits neuronal loss and alleviates gliosis in the gerbil hippocampal CA1 area induced by transient global cerebral ischemia. Anatomy & Cell Biology, 50(4), 284-292. https://doi.org/10.5115/acb.2017.50.4.284

Pivot, X. ., Bondarenko, I. ., Nowecki, Z. ., Dvorkin, M. ., Trishkina, E. ., Ahn, J. ., … Lim, J. . (2018). Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive.. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017740126. https://doi.org/10.1200/JCO.2017.74.0126 (Original work published 2018)